Related Experiment Videos
Career burnout among pediatric oncologists
Michael Roth1, Kerry Morrone, Karen Moody
1Division of Pediatric Hematology/Oncology, Children's Hospital at Montefiore, Bronx, New York 10467, USA. mroth@montefiore.org
Pediatric Blood & Cancer
|May 7, 2011
Summary
Burnout affects over 70% of pediatric oncologists, with women and early-career physicians at higher risk. Work-life balance and institutional support significantly reduce burnout rates.
Area of Science:
- Medical Research
- Oncology
- Occupational Health
Background:
- Burnout is a syndrome of emotional exhaustion, depersonalization, and reduced accomplishment.
- Pediatric oncologists face high risks due to the nature of their work with critically ill patients.
- This study investigates burnout prevalence and risk factors in pediatric oncologists.
Purpose of the Study:
- To determine the prevalence of burnout among pediatric oncologists.
- To identify work-related and lifestyle factors contributing to burnout in this group.
- To assess the impact of institutional support on burnout rates.
Main Methods:
- A survey was distributed to 1,047 practicing pediatric oncologists via email.
- The Maslach Burnout Inventory (MBI) and questions on work/lifestyle factors were used.
- A response rate of 40% (410 oncologists) was achieved.
Main Results:
- 38% reported high burnout; 72% reported at least moderate burnout.
- Higher burnout rates were observed in women and physicians with <10 years of practice.
- Life satisfaction, debriefing forums, and burnout support services were associated with lower burnout.
Conclusions:
- Burnout is highly prevalent, affecting approximately three-quarters of pediatric oncologists.
- Interventions to prevent and treat burnout require further investigation.
- Work-life balance and institutional support systems are crucial for mitigating burnout.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:27Ethical Issues
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Concerns in Healthcare:
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...